OrbiMed’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-253,108
| Closed | -$5.79M | – | 155 |
|
|
2020
Q3 | $5.79M | Sell |
253,108
-129,292
| -34% | -$2.96M | 0.07% | 121 |
|
|
2020
Q2 | $8M | Buy |
+382,400
| New | +$8M | 0.11% | 108 |
|
|
2018
Q4 | – | Sell |
-775,000
| Closed | -$19.1M | – | 139 |
|
|
2018
Q3 | $19.1M | Hold |
775,000
| – | – | 0.23% | 91 |
|
|
2018
Q2 | $15.2M | Hold |
775,000
| – | – | 0.18% | 101 |
|
|
2018
Q1 | $14.5M | Buy |
+775,000
| New | +$14.5M | 0.18% | 93 |
|
|
2017
Q1 | – | Sell |
-462,325
| Closed | -$11.3M | – | 137 |
|
|
2016
Q4 | $11.3M | Hold |
462,325
| – | – | 0.14% | 86 |
|
|
2016
Q3 | $17.5M | Buy |
462,325
+114,575
| +33% | +$4.34M | 0.2% | 77 |
|
|
2016
Q2 | $10.3M | Hold |
347,750
| – | – | 0.11% | 88 |
|
|
2016
Q1 | $10.3M | Buy |
347,750
+241,500
| +227% | +$7.15M | 0.11% | 91 |
|
|
2015
Q4 | $4.82M | Hold |
106,250
| – | – | 0.04% | 109 |
|
|
2015
Q3 | $4M | Buy |
+106,250
| New | +$4M | 0.04% | 111 |
|